-
Karyopharm Therapeutics' (KPTI) "Buy" Rating Reiterated at HC Wainwright
来源: Buzz FX / 15 1月 2025 06:26:16 America/Chicago
Karyopharm Therapeutics' (KPTI) "Buy" Rating Reiterated at HC Wainwright Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Karyopharm Therapeutics ( NASDAQ:KPTI - Get Free Report ) 's stock had its "buy" rating reiterat
Read more...